Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in ...
13:19 EDT 30 Jun 2012 | LaMerie
- Clinical Results for Lipegfilgrastim and Balugrastim Highlighted at Oncology Conference;
- Teva Committed to Further Advancing Its Biologic Oncology Programs -
Original Article: Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in ...
More From BioPortfolio on "Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in ..."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
